Evidence map›Paper›PMID 37453954›Full record

ArticleMedical oncology (Northwood, London, England)2023

Alpha-lipoic acid induced apoptosis of PC3 prostate cancer cells through an alteration on mitochondrial membrane depolarization and MMP-9 mRNA expression.

Aybuke Celik, Filiz Bakar-Ates

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aybuke CelikDepartment of Biochemistry, Faculty of Pharmacy, Ankara University, Anadolu, 06560, Ankara, Turkey.ORCID http://orcid.org/0000-0001-9354-5373
Filiz Bakar-AtesDepartment of Biochemistry, Faculty of Pharmacy, Ankara University, Anadolu, 06560, Ankara, Turkey. fbakar@ankara.edu.tr.ORCID http://orcid.org/0000-0003-2809-8946
Ankara University · TR

Funding

Ankara Universitesi Research Project number 21H0237001.
6 · The paper itself

Abstract

Cancer has become an important cause of mortality and morbidity in the world. Over the past decades, biomedical research revealed insights into the molecular events and signaling pathways involved in carcinogenesis and cancer progression. Matrix metalloproteinases (MMPs) are a diverse family of enzymes that can degrade various components of the extracellular matrix and are considered as potential diagnostic and prognostic biomarkers for many cancer types and cancer stages. Recently, studies on the role of natural-origin active substances in the prevention of cancer development gained importance. Among them, the α-lipoic acid, which is commonly found in plants, displayed potent anti-proliferative effects on cancer cell lines. However, the effect of the compound on the induction of apoptosis and mRNA expression of MMPs in human prostate cancer cells remains unclear. The present study aimed to evaluate the anti-proliferative and apoptotic activity of α-lipoic acid in human PC3 prostate carcinoma cells considering different concentrations and exposure durations. The findings showed that, α-lipoic acid significantly decreased PC3 cell viability with an IC

Indexed as

Prostatic NeoplasmsThioctic AcidApoptosisCell Line, TumorHumansMaleMatrix Metalloproteinase 9Matrix MetalloproteinasesMitochondrial MembranesPC-3 CellsRNA, MessengerMatrix Metalloproteinase 9Matrix MetalloproteinasesRNA, MessengerThioctic AcidApoptosisMatrix metalloproteinaseProliferationProstate cancerα-lipoic acid

Identifiers

PMID37453954
OpenAlexW4384405644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.